ATYPICAL HELLP SYNDROME OR ATYPICAL HEMOLYTIC UREMIC SYNDROME?
- Авторлар: KALACHIN K.A1, PYREGOV A.V1, FEDOROVA T.A1, GRISHCHUK K.I1, SHMAKOV R.G1
-
Мекемелер:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Шығарылым: № 1 (2017)
- Беттер: 94-102
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247859
- ID: 247859
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
K. KALACHIN
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: Konstantin.Kalachin@yandex.ru
anesthesiologist-resuscitator Moscow 117997, Ac. Oparina str. 4, Russia
A. PYREGOV
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: pyregov@mail.ru
MD, Head of the Department of Anesthesiology and Resuscitation Moscow 117997, Ac. Oparina str. 4, Russia
T. FEDOROVA
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: t_fedorova@oparina4.ru
MD, Professor, Head of the Department of Transfusion and extracorporeal blood correction Moscow 117997, Ac. Oparina str. 4, Russia
K. GRISHCHUK
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: K_grischuk@oparina4.ru
anesthesiologist-resuscitator Moscow 117997, Ac. Oparina str. 4, Russia
R. SHMAKOV
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: r_shmakov@oparina4.ru
chief physician Moscow 117997, Ac. Oparina str. 4, Russia
Әдебиет тізімі
- Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 1982; 142(2): 159-67.
- Серов В.Н., Сухих Г.Т., Баранов И.И., Пырегов А.В., Тютюнник В.Л., Шмаков Р.Г. Неотложные состояния в акушерстве. Руководство для врачей. М.: ГЭОТАР-Медиа; 2011. 784с.
- Aydin S., Ersan F., Ark C., Arioglu Aydin C. Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes. J. Obstet. Gynaecol. Res. 2014; 40(4): 932-40.
- Abildgaard U., Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 166(2): 117-23.
- Dusse L.M., Alpoim P.N., Silva J.T., Rios D.R., Brandao A.H., Cabral A.C. Revisiting HELLP syndrome. Clin. Chim. Acta. 2015; 451(Pt B): 117-20.
- Martin J.N. Jr., Rinehart B.K., May W.L., Magann E.F., Terrone D.A., Blake P.G. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am. J. Obstet. Gynecol. 1999; 180(6, Pt 1): 1373-84.
- Виноградова М.А., Федорова Т.А., Чупрынин В.Д., Тютюник В.Л., Кан Н.Е., Вередченко А.В., Хилькевич Е.Г. Рациональная комплексная терапия с проведением симультанных операций при рефрактерной иммунной тромбоцитопении и беременности. Акушерство и гинекология. 2013; 9: 118-22.
- Burrows R.F., Kelton J.G. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N. Engl. J. Med. 1993; 329(20): 1463-6.
- Sainio S., Kekomaki R., Riikonen S., Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet. Gynecol. Scand. 2000; 79(9): 744-9.
- Rodger M., Sheppard D., Gdndara E., Tinmouth A. Haematological problems in obstetrics. Best Pract. Res. Clin. Obstet. Gynaecol. 2015; 29(5): 671-84.
- Макацария А.Д., Акиньшина С.В., Бицадзе В.О. Преэклампсия и HELLP-синдром как проявление тромботической микроангиопатии. Акушерство и гинекология. 2014; 4: 4-10.
- Martin J.N. Jr., Stedman C. Imitators of preeclampsia and HELLP syndrome. Obstet. Gynecol. Clin. North Am. 1991; 18: 181-98.
- Sibai B. Imitators of severe preeclampsia. Obstet. Gynecol. 2007; 109(4): 956-66.
- Pourrat O., Coudroy R., Pierre F. Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 189: 68-72.
- Шилов Е.М., ред. Национальные клинические рекомендации по лечению отдельных нефропатий. Сборник клинических рекомендаций. М.: Белый Ветер; 2015. 312с.
- Gaggl M., Aigner C., Sunder-Plassmann G., Schmidt A. Thrombotic microangiopathy: relevant new aspects for intensive care physicians. Med. Klin. Intensivmed. Notfmed. 2016; 111(5): 434-9.
- Thomas M.R., Robinson S., Scully M.A. How we manage thrombotic microangiopathies in pregnancy. Br. J. Haematol. 2016; 173(6): 821-30.
- Fakhouri F. Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus. Apher. Sci. 2016; 54(2): 199-202.
- Tsokos M., Longauer F., Kardosova V., Gavel A., Anders S., Schulz F. Maternal death in pregnancy from HELLP syndrome. A report of three medico-legal autopsy cases with special reference to distinctive histopathological alterations. Int. J. Legal Med. 2002; 116(1): 50-3.
- Сидорова И.С., Милованов А.П., Никитина Н.А., Рзаева А.А. Патоморфологические особенности изменений в почках при тяжелой преэклампсии. Российский вестник акушера-гинеколога. 2014; 14(1): 4-9.
- Wijnsma K.L., van Bommel S.A., van der Velden T., Volokhina E., Schreuder M.F., van den Heuvel L.P., van de Kar N.C. Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr. Nephrol. 2016; 31(11): 2163-70.
- Ake J.A., Jelacic S., Ciol M.A., Watkins S.L., Murray K.F., Christie D.L. et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics. 2005; 115(6): e673-80.
- Leu H., Sugimoto N., Shimizu M., Toma T., Wada T., Ohta K., Yachie A. Tumor necrosis factor-а modifies the effects of Shiga toxin on glial cells. Int. Immunopharmacol. 2016; 38: 139-43.
- Mannucci P.M., Peyvandi Е.В. TTP and ADAMTS13: when is testing appropriate? Hematol. Am. Soc. Hematol. Educ. Program. 2007: 121-6.
- Kentouche K., Voigt A., Schleussner E., Schneppenheim R., Budde U., Beck J.F. et al. Pregnancy in Upshaw-Schulman syndrome. Hamostaseologie. 2013; 33(2): 144-8.
- Pavenski K., Cataland S., Kremer Hovinga J., Thomas M., Vanhoorelbeke K. Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings. Expert Rev. Hematol. 2016; 9(8): 733-5.
- Scully M., Hunt B.J., Benjamin S., Liesner R., Rose P., Peyvandi F. et al.; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br. J. Haematol. 2012; 158(3): 323-35.
- Rafiq A., Tariq H., Abbas N., Shenoy R. Atypical hemolytic-uremic syndrome: a case report and literature review. Am. J. Case Rep. 2015; 16: 109-14.
- Cataland S.R., Wu H.M. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies. Eur. J. Intern. Med. 2013; 24(6): 486-91.
- Réti M., Farkas P., Csuka D., Razso K., Schlammadinger Á., Udvardy M.L. et al. Complement activation in thrombotic thrombocytopenic purpura. Thromb. Haemost. 2012; 10(5): 791-8.
- Loirat C., Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J. Rare Dis. 2011; 6: 60.
- Fakhouri F., Hourmant M., Campistol J.M., Cataland S.R., Espinosa M., Gaber A.O. et al. Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial. Am. J. Kidney Dis. 2016; 68(1): 84-93.
- Долгушина В.Ф., Чулков В.С., Вереина Н.К., Синицын С.П. Акушерские осложнения при различных формах артериальной гипертензии у беременных. Акушерство и гинекология. 2013; 10: 33-9.